Cargando…

Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme

BACKGROUND: External randomised pilot trials aim to assess whether a future definitive randomised controlled trial (RCT) is feasible. Pre-specified progression criteria help guide the interpretation of pilot trial findings to decide whether, and how, a definitive trial should be conducted. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellor, Katie, Harwood, James, Hejdenberg, Jennie, Morgan, Ben, Dutton, Susan J., Hopewell, Sally
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640878/
https://www.ncbi.nlm.nih.gov/pubmed/36348460
http://dx.doi.org/10.1186/s13063-022-06868-8
_version_ 1784825961329459200
author Mellor, Katie
Harwood, James
Hejdenberg, Jennie
Morgan, Ben
Dutton, Susan J.
Hopewell, Sally
author_facet Mellor, Katie
Harwood, James
Hejdenberg, Jennie
Morgan, Ben
Dutton, Susan J.
Hopewell, Sally
author_sort Mellor, Katie
collection PubMed
description BACKGROUND: External randomised pilot trials aim to assess whether a future definitive randomised controlled trial (RCT) is feasible. Pre-specified progression criteria help guide the interpretation of pilot trial findings to decide whether, and how, a definitive trial should be conducted. We aimed to examine how researchers report and plan to assess progression criteria in external pilot trial funding applications submitted to the NIHR Research for Patient Benefit Programme. METHODS: We conducted a cross-sectional study of progression criteria inclusion in Stage 1 (outline) and corresponding Stage 2 (full) funding applications for external randomised external pilot trials submitted to NIHR RfPB between July 2017 and July 2019. RESULTS: Of the 100 Stage 1 outline applications assessed, 95 were eligible for inclusion (of these, 52 were invited to Stage 2 full application; 43 were rejected) and 49/52 were eligible for inclusion at Stage 2 full application (of these, 35 were awarded funding; 14 were rejected). Over half of applications assessed at Stage 1 (48/95, 51%), and 73% of those assessed at Stage 2 (36/49) included progression criteria in their research plans. Progression criteria were most often reported in a stop-go format, often with additional specified factors that should be considered when determining feasibility (Stage 1 33/48, 69%; Stage 2 21/36, 58%). Recruitment and retention were the most frequent indicators of feasibility to inform progression criteria. One-third of applications provided some justification or rationale for their targets (Stage 1 16/48, 33%; Stage 2 12/36, 33%). Funding committee feedback mentioned progression criteria in over 20% of applications (Stage 1 22/95, 23%; Stage 2 11/49, 22%) to either request the addition of progression criteria or provide justification for the criteria stipulated. CONCLUSIONS: Our findings indicate that researchers do not always include progression criteria in external randomised pilot trial applications submitted to research funders. This can result in a lack of transparency in the assessment of randomised pilot trial feasibility. TRIAL REGISTRATION: Open Science Framework osf.io/89ap7, registered 29th June 2021.
format Online
Article
Text
id pubmed-9640878
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96408782022-11-14 Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme Mellor, Katie Harwood, James Hejdenberg, Jennie Morgan, Ben Dutton, Susan J. Hopewell, Sally Trials Research BACKGROUND: External randomised pilot trials aim to assess whether a future definitive randomised controlled trial (RCT) is feasible. Pre-specified progression criteria help guide the interpretation of pilot trial findings to decide whether, and how, a definitive trial should be conducted. We aimed to examine how researchers report and plan to assess progression criteria in external pilot trial funding applications submitted to the NIHR Research for Patient Benefit Programme. METHODS: We conducted a cross-sectional study of progression criteria inclusion in Stage 1 (outline) and corresponding Stage 2 (full) funding applications for external randomised external pilot trials submitted to NIHR RfPB between July 2017 and July 2019. RESULTS: Of the 100 Stage 1 outline applications assessed, 95 were eligible for inclusion (of these, 52 were invited to Stage 2 full application; 43 were rejected) and 49/52 were eligible for inclusion at Stage 2 full application (of these, 35 were awarded funding; 14 were rejected). Over half of applications assessed at Stage 1 (48/95, 51%), and 73% of those assessed at Stage 2 (36/49) included progression criteria in their research plans. Progression criteria were most often reported in a stop-go format, often with additional specified factors that should be considered when determining feasibility (Stage 1 33/48, 69%; Stage 2 21/36, 58%). Recruitment and retention were the most frequent indicators of feasibility to inform progression criteria. One-third of applications provided some justification or rationale for their targets (Stage 1 16/48, 33%; Stage 2 12/36, 33%). Funding committee feedback mentioned progression criteria in over 20% of applications (Stage 1 22/95, 23%; Stage 2 11/49, 22%) to either request the addition of progression criteria or provide justification for the criteria stipulated. CONCLUSIONS: Our findings indicate that researchers do not always include progression criteria in external randomised pilot trial applications submitted to research funders. This can result in a lack of transparency in the assessment of randomised pilot trial feasibility. TRIAL REGISTRATION: Open Science Framework osf.io/89ap7, registered 29th June 2021. BioMed Central 2022-11-08 /pmc/articles/PMC9640878/ /pubmed/36348460 http://dx.doi.org/10.1186/s13063-022-06868-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mellor, Katie
Harwood, James
Hejdenberg, Jennie
Morgan, Ben
Dutton, Susan J.
Hopewell, Sally
Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme
title Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme
title_full Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme
title_fullStr Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme
title_full_unstemmed Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme
title_short Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme
title_sort inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the nihr research for patient benefit programme
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640878/
https://www.ncbi.nlm.nih.gov/pubmed/36348460
http://dx.doi.org/10.1186/s13063-022-06868-8
work_keys_str_mv AT mellorkatie inclusionofprogressioncriteriainexternalrandomisedpilottrialsacrosssectionalstudyoffundingapplicationssubmittedtothenihrresearchforpatientbenefitprogramme
AT harwoodjames inclusionofprogressioncriteriainexternalrandomisedpilottrialsacrosssectionalstudyoffundingapplicationssubmittedtothenihrresearchforpatientbenefitprogramme
AT hejdenbergjennie inclusionofprogressioncriteriainexternalrandomisedpilottrialsacrosssectionalstudyoffundingapplicationssubmittedtothenihrresearchforpatientbenefitprogramme
AT morganben inclusionofprogressioncriteriainexternalrandomisedpilottrialsacrosssectionalstudyoffundingapplicationssubmittedtothenihrresearchforpatientbenefitprogramme
AT duttonsusanj inclusionofprogressioncriteriainexternalrandomisedpilottrialsacrosssectionalstudyoffundingapplicationssubmittedtothenihrresearchforpatientbenefitprogramme
AT hopewellsally inclusionofprogressioncriteriainexternalrandomisedpilottrialsacrosssectionalstudyoffundingapplicationssubmittedtothenihrresearchforpatientbenefitprogramme